ENSG
NASDAQ · Health Care
Ensign Group Inc/The
$164.07
+5.18 (+3.26%)
Financial Highlights (FY 2026)
Revenue
5.02B
Net Income
341.47M
Gross Margin
21.1%
Profit Margin
6.8%
Rev Growth
+18.7%
D/E Ratio
0.06
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 21.1% | 21.1% | 41.2% | 41.2% |
| Operating Margin | 8.4% | 7.6% | 11.7% | 14.0% |
| Profit Margin | 6.8% | 6.5% | 10.8% | 11.0% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 5.02B | 4.23B | 4.21B | 4.15B |
| Gross Profit | 1.06B | 891.43M | 1.73B | 1.71B |
| Operating Income | 422.27M | 320.23M | 490.49M | 578.58M |
| Net Income | 341.47M | 258.95M | 452.95M | 453.91M |
| Gross Margin | 21.1% | 21.1% | 41.2% | 41.2% |
| Operating Margin | 8.4% | 7.6% | 11.7% | 14.0% |
| Profit Margin | 6.8% | 6.5% | 10.8% | 11.0% |
| Rev Growth | +18.7% | +18.7% | +1.5% | -7.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 268.10M | 268.10M | 3.37B | 3.51B |
| Total Equity | 4.22B | 4.22B | 4.63B | 4.21B |
| D/E Ratio | 0.06 | 0.06 | 0.73 | 0.83 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 525.79M | 420.88M | 812.11M | 863.45M |
| Free Cash Flow | — | — | 544.25M | 422.07M |